Evidence map›Paper›PMID 30148836›Full record

ArticlePloS one2018

The effects of insulin on the inflammatory activity of BV2 microglia.

Fiona Brabazon, Sara Bermudez, Michael Shaughness, Guzal Khayrullina, Kimberly R Byrnes

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Avicenna journal of phytomedicine · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. The Arp2/3 complex is required forbioRxiv : the preprint server for biology · 2025
    Article
  12. Physical confinement and phagocytic uptake induce directional migration.bioRxiv : the preprint server for biology · 2025
    Article
  13. Review
  14. Personalized, Precision Medicine to Cure Alzheimer's Dementia: Approach #1.International journal of molecular sciences · 2024
    Review
  15. Formulating Treatment to Cure Alzheimer's Dementia: Approach #2.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Intranasal Insulin for Treatment of Persistent Post-COVID-19 Olfactory Dysfunction: A Scoping Review.Journal of community hospital internal medicine perspectives · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fiona BrabazonNeuroscience Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.
Sara BermudezDepartment of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.
Michael ShaughnessNeuroscience Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.
Guzal KhayrullinaDepartment of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.
Kimberly R ByrnesNeuroscience Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.ORCID 0000-0002-7501-7734
Uniformed Services University of the Health Sciences · US

Funding

The NADPH oxidase enzyme as a therapeutic target after Spinal Cord InjuryR01NS073667 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BYRNES, KIMBERLY · 2012 to 2016
$1.3M
NINDS NIH HHS R01 NS073667
6 · The paper itself

Abstract

Microglia are the macrophages of the central nervous system (CNS), which function to monitor and maintain homeostasis. Microglial activation occurs after CNS injury, infection or disease. Prolonged microglial activation is detrimental to the CNS as they produce nitric oxide (NO), reactive oxygen species (ROS) and pro-inflammatory cytokines, resulting in neuronal cell dysfunction and death. Microglial activation is implicated in the neurological deficits following traumatic brain injury (TBI) and Alzheimer's disease. Intranasal insulin administration is a promising treatment of Alzheimer's disease and TBI. However, the exact effect of insulin on microglia is currently unclear. The goal of this study was therefore to examine the effect of insulin administration on activated microglia. The microglial cell line BV2 were exposed to a pro-inflammatory stimulus, lipopolysaccharide (LPS), followed by insulin administration. Outcome measures were conducted at 24 hours after treatment. In vitro assays quantified NO and ROS production. Western blot, immunocytochemistry and phagocytosis assay further examined the effect of insulin on microglial activity. Insulin treatment significantly reduced NO, ROS and TNFα production and increased phagocytic activity. Insulin treatment also significantly reduced iNOS expression, but had no significant effect on any other M1 or M2 macrophage polarization marker examined. These data suggest that insulin has very specific effects to reduce pro-inflammatory or chemoattractant properties of microglia, and this may be one mechanism by which insulin has beneficial effects in CNS injury or neurodegenerative conditions.

Indexed as

Animalsbeta-N-AcetylhexosaminidasesCell LineInflammationInsulinLectinsLectins, C-TypeLipopolysaccharidesMannose-Binding LectinsMannose ReceptorMiceMicrogliaNitric OxidePhagocytosisProto-Oncogene Proteins c-aktReactive Oxygen Speciesbeta-N-AcetylhexosaminidasesChil3 protein, mouseInsulinLectinsLectins, C-TypeLipopolysaccharidesMannose-Binding LectinsMannose ReceptorNitric OxideProto-Oncogene Proteins c-aktReactive Oxygen SpeciesReceptors, Cell SurfaceTumor Necrosis Factor-alpha

Identifiers

PMID30148836
PMCPMC6110462
OpenAlexW2888852351

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.